IP Library Granted Patent US 10,813,645
Granted Patent B2
US 10,813,645 · App. 16/163,287 · Granted Oct 27, 2020

Filamentary devices for treatment of vascular defects

Inventors: Todd J. Hewitt (Laguna Niguel, CA); Brian E. Merritt (San Clemente, CA); William R. Patterson (Huntington Beach, CA)
Assignee: SEQUENT MEDICAL, INC.
A61B17/12113A61B17/12013A61B17/12031A61B17/12118A61B17/12172A61B17/12177A61B2017/00539A61B2017/00778A61B2017/00867A61B2017/1205A61B2017/1209A61B2017/12068A61B2017/12095A61B2090/3966
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,813,645
App. No.
16/163,287
Granted
Oct 27, 2020
Kind
B2
Abstract

Devices and methods for treatment of a patient's vasculature are described. Embodiments may include a resilient self-expanding permeable implant having a radially constrained elongated state configured for delivery within a catheter lumen and an expanded state with a longitudinally shortened configuration, and a plurality of elongate filaments which are woven together. Each of the plurality of elongate filaments may have a diameter between about 0.0005 and about 0.005 inches. The implant includes at least some filaments consisting of nitinol and at least some composite filaments that are drawn filled tube wires comprising an external nitinol tube and a highly radiopaque material concentrically disposed within the external tube. The implant has at least about 40% composite filaments relative to a total number of filaments, and wherein a total number of filaments is about 10 to about 300.

Claims (25)

1. A device for treatment of a patient's vasculature, comprising:

a resilient self-expanding permeable implant including a radially constrained elongated state configured for delivery within a catheter lumen, an expanded state with a longitudinally shortened configuration relative to the radially constrained state, and a plurality of elongate filaments which are woven together, wherein each of the plurality of elongate filaments has a diameter between about 0.0005 inches to about 0.005 inches, the permeable implant comprising at least some filaments consisting of nitinol and at least some composite filaments, the composite filaments comprising drawn filled tube wires comprising an external nitinol tube and a highly radiopaque material concentrically disposed within the external tube, and wherein the permeable implant has at least about 40% composite filaments relative to a total number of filaments, and wherein a total number of filaments is about 10 to about 300.

2. The device of claim 1 , wherein the drawn filled tube wires have a fill ratio of cross sectional area selected from the group consisting of between about 10% and about 50%, between about 20% and about 40%, and between about 25% and about 35%.

3. The device of claim 1 , wherein the highly radiopaque material of the composite filaments comprises a material selected from the group consisting of tantalum, platinum, and gold.

4. The device of claim 1 , wherein each of the composite filaments has a diameter selected from the group consisting of 0.00075″, 0.001″, 0.0015″, and 0.00125″.

5. The device of claim 1 , wherein the expanded state has a globular configuration.

6. The device of claim 1 , wherein the implant is a stent.

7. The device of claim 1 , wherein the plurality of elongate filaments are secured relative to each other at a proximal end of the permeable implant.

8. The device of claim 1 , wherein the total number of filaments is selected from the group consisting of about 70 to about 300, about 10 to about 100, about 60 to about 80, about 100 to about 200, and about 80 to about 180.

9. The device of claim 1 , wherein each of the plurality of elongate filaments has a diameter selected from the group consisting of between about 0.0008 inches to about 0.004 inches, between about 0.001 inches to about 0.003 inches, and between about 0.0004 inches to about 0.002 inches.

10. A method for treating a patient's vasculature, comprising the steps of:

providing a resilient self-expanding permeable implant including a radially constrained elongated state configured for delivery within a catheter lumen, an expanded state with a longitudinally shortened configuration relative to the radially constrained state, and a plurality of elongate filaments which are woven together, wherein each of the plurality of elongate filaments has a diameter between about 0.0005 inches to about 0.005 inches, the permeable implant comprising at least some filaments consisting of nitinol and at least some composite filaments, the composite filaments comprising drawn filled tube wires comprising an external nitinol tube and a highly radiopaque material concentrically disposed within the external tube, and wherein the permeable implant has at least about 40% composite filaments relative to a total number of filaments, and wherein a total number of filaments is about 10 to about 300;

advancing the permeable implant in the radially constrained state within a catheter to a region of interest within the vasculature;

deploying the permeable implant in the region of interest, wherein the permeable implant expands to the expanded state within the region of interest; and

withdrawing the catheter from the region of interest after deploying the permeable implant, wherein the permeable implant is in the expanded state after the catheter is withdrawn.

11. The method of claim 10 , wherein the drawn filled tube wires have a fill ratio of cross sectional area selected from the group consisting of between about 10% and about 50%, between about 20% and about 40%, and between about 25% and about 35%.

12. The method of claim 10 , wherein the highly radiopaque material of the composite filaments comprises a material selected from the group consisting of tantalum, platinum, and gold.

13. The method of claim 10 , wherein each of the composite filaments has a diameter selected from the group consisting of 0.00075″, 0.001″, 0.0015″, and 0.00125″.

14. The method of claim 10 , wherein the expanded state has a globular configuration.

15. The method of claim 10 , wherein the implant is a stent.

16. The method of claim 10 , wherein the plurality of elongate filaments are secured relative to each other at a proximal end of the permeable implant.

17. The method of claim 10 , wherein the region of interest is a cerebral aneurysm.

18. The method of claim 10 , wherein the region of interest is a vessel.

19. The method of claim 10 , wherein the total number of filaments is selected from the group consisting of about 70 to about 300, about 10 to about 100, about 60 to about 80, about 100 to about 200, and about 80 to about 180.

20. The method of claim 10 , wherein each of the plurality of elongate filaments has a diameter selected from the group consisting of between about 0.0008 inches to about 0.004 inches, between about 0.001 inches to about 0.003 inches, and between about 0.0004 inches to about 0.002 inches.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME ON THE ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED AT REEL: 062776 FRAME: 0086. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 19, 2023
From: SEQUENT MEDICAL, INC.
To: MICROVENTION, INC.
Reel/Frame 063374/0585 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2023
From: SEQUENT MEDICAL, INC.
To: MICROVENTION, INC.
Reel/Frame 062776/0086 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2018
From: HEWITT, TODD J; MERRITT, BRIAN E; PATTERSON, WILLIAM R
To: SEQUENT MEDICAL, INC.
Reel/Frame 047202/0603 →
Continuity (7)
Continuation 15336634 · Oct 27, 2016
Continuation 15071632 · Mar 16, 2016
Continuation 14871352 · Sep 30, 2015
Continuation 14743627 · Jun 18, 2015
Continuation 14459638 · Aug 14, 2014
Provisional Application 61866993 · Aug 16, 2013
Related Publication 20190192166A1 · Jun 27, 2019
Cited By (7)
US 12,251,112 US 12,285,175 US 12,303,153 US 12,318,091 US 12,408,925 US 12,414,775 US 12,446,891